DailyRounds, Marrow Cofounder Deepu Sebin Quits

Healthcare-focused edtech platform DailyRounds on Thursday said its cofounder Deepu Sebin has quit the company and its NEET PG test-preparation platform Marrow.

The startup also said that it has promoted Vineet Bagri, who has closely worked with Sebin for over three years, to the position of CEO. Bagri earlier worked with the platform as business head.

“After 8 incredible years of leadership, we bid farewell to our founder Dr. Deepu Sebin as he officially exits from his role at Marrow and DailyRounds in all capacities,” DailyRounds said in a LinkedIn post.

Sebin worked as the CEO of the startup from its inception till April 2022. Later, he took over as the representative officer of the Bengaluru-based platform.

Meanwhile, Bagri worked with companies like ClassKlap, IMAX Program, Tally Solutions, Dabur India and Bayer before joining DailyRounds.

DailyRounds, founded in 2015 by Sebin, Priyank Choubey and Nimmi Cherian, is an online community for physicians, doctors, medical schools, and surgeon societies to publish clinical cases and allied information. 

The startup has a network of over 300K doctors. It claims that 400 new doctors join its platform on a daily basis. It also runs test-preparation platform Marrow, which helps medical students prepare for NEET PG exams. Marrow offers multiple subscription plans to its users and claims that the platform is used by over 2 Lakh students.

In 2019, Japanese healthtech company M3’s Indian subsidiary M3 India acquired a majority stake in DailyRounds’ parent company Neuroglia Health Pvt Ltd (NHPL). 

The startup has raised over $500K in funding and is backed by the likes of Accel, Beenos Partners, Powerhouse Ventures, Microsoft Accelerator Bangalore, and GSF. 

Even as most of the platforms in the edtech sector are struggling with mounting losses, DailyRounds’ profit rose to INR 198.09 Cr in FY22 from INR 178.14 Cr in FY21.

In comparison, edtech unicorn Unacademy reported a net loss of INR 2,848 Cr in FY22, while Vedantu posted a loss of INR 696 Cr during the year under review.

Note: We at Inc42 take our ethics very seriously. More information about it can be found here.